Trial | Operative time; median (range) or mean ± SD, min | p value | |
---|---|---|---|
Open surgery | Laparoscopic surgery | ||
Colon cancer | |||
COLOR10 | 115 (70–180) | 145 (102–230) | < 0.001 |
COST16 | 95 (27–435) | 150 (35–450) | < 0.001 |
Barcelona23 | 118 ± 45 | 142 ± 52 | 0.001 |
Liang et al.24 | 184 ± 31 | 224 ± 45 | < 0.001 |
LAPKON II26 | 138 ± 45 | 183 ± 61 | < 0.001 |
ALCCaS27 | 107 (45–250) | 158 (49–365) | < 0.001 |
Rectal cancer | |||
Liang et al.33 | 119 ± 22 | 138 ± 24 | < 0.001 |
COREAN34 | 197 ± 63 | 245 ± 75 | < 0.001 |
Lujan et al.36 | 173 ± 59 | 194 ± 45 | 0.020 |
Ng et al.37 | 154 ± 70 | 213 ± 59 | < 0.001 |
Ng et al.39 | 164 ± 43 | 214 ± 46 | < 0.001 |
Braga et al.41 | 209 ± 70 | 262 ± 72 | < 0.001 |
Zhou et al.42 | 106 (80–230) | 120 (110–220) | 0.05 |
ALCCaS = Australasian Laparoscopic Colon Cancer Study; COLOR = Colon cancer Laparoscopic or Open Resection; COREAN = Comparison of Open versus laparoscopic surgery for mid and low Rectal cancer After Neoadjuvant chemoradiotherapy; COST = Clinical Outcomes of Surgical Therapy; SD = standard deviation.